Earnings call transcript Q4 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Welcome to the Sensus Healthcare Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions].

Please also note that this event is being recorded today. I would now like to turn the conference over to Kim Golodetz with LHA Investor Relations. Please go ahead.

Kim Golodetz

you. Thank Golodetz Kim LHA. with is This for Thank today's in you all call. participating

Javier Joe from President and and Officer. Sensus me Sardano, and Chief Healthcare Counsel; Sardano, Joining Michael are Chairman Financial Officer; Chief General Rampolla, Executive

other assumes, a or historical during call expressions of in facts activities discussed similar federal that As will laws. anticipates All the Healthcare statements today's some address matters contain forward-looking of or that plans, reminder, should statements intends be may within future securities the The update XX-K of forward-looking forward-looking and and management's statements. expects, this XX-Q. any the meaning believes, as the other will, Sensus than required forward-looking on occur obligation All Sensus based date February information in company's call, Forms no currently XXXX. statements statements risks X, except available statements to are law. are subject conference Healthcare uncertainties by the or as forward-looking described revise of as and undertakes beliefs to are

today's investors During these information substitute will useful certain to not provide measures Sensus made for financial for be measures. they considered non-GAAP as believes should be a call, yet conference references for should results today's GAAP. viewed be nor a results press release. to as results with financial GAAP in determined is accordance A substitute non-GAAP they of in reconciliation operating GAAP included

Sardano. to With turn that to said, Joe? Joe like call over the I'd

Joseph Sardano

noninvasive remains physicians our highest of greater the with our before cancer Sensus by Kim, patients. afternoon, superficial technology both ever therapy We all treatment you that Thank with everyone. even plan. confidence skin good of pieces believe for place and the is address the execution of in you, #X history today better I Healthcare choice for and radiation our in business than positioned today

market making and program, acquisition Our our value improved our acquisition an with patient the combined technology easy our provides transplant. tool, excellent customers lease of fair with reimbursement, lead

great to which reassurances. technology outcomes high-resolution provides improved leads and see-and-treat ultrasound new and Our capability, patient

we revenue quarter executed the fourth delivering XXXX, and strong throughout During strategically and profits.

of Sensus FDA the and staff aesthetic sales half XXXX, and receive our steps Sentinel increasing included new we inventory, are took further clearance Importantly, the anticipated to number that developing future success. latter These in products solutions growth, to of for a position IT drive building capability headcount and strategies investing exceptional to marketing programs, in also capabilities. assembling and

our X skin As along Mohs cancer some we've skin for time, of cancer, better radiation reimbursement suggesting and for saying with with have reimbursement surgery support they superficial January Medicaid 'XX, therapy powerful of to we in develop programs. upwards for the by Americans lower will X centers our in tailwinds data been for that and main when non-melanoma Recall skin cancer. received non-melanoma that a our from reimbursement revalued SRT code Medicare in XX% for therapy SRT course improved services

In codes addition, ancillary received a boost. double-digit

to SRT reimbursement these noninvasive continue are changes, and best of cancer. and on more practitioners capitalize the for as We a treatment skin practice non-melanoma more recognizing

trade investment shows. return education ongoing, dermatology and SRT is at highlighting physician rigorous Our especially improved on conferences program, the for

provides of view including recently Winter ultrasound, new a followed single-use which important state-of-the-art, the key be leader, best weekend South up industry's ergonomic disposables. important new opinion Gold, benefits. the launched a fact, Miami, solid-state, and another at Dr. with this Clinical We the In high-frequency Symposium This X upgrades at discussing in be later the this weeks Beach Dr. design leader, will will probe Miami and Michael utilizes Conference epidermis to Mark its SRT in Nestor. by opinion system, key

Vision purchases system, leading SRT-XXX we Vision lease physicians SRT last support launched continues interest become its to fair has among of our garnering The program year and This feature-rich earlier percentage market to upgrade system system product. sales the increase. SRT-XXX continues our is and value of

want, our is hospital While our and on maintaining and core growth. recently to providing and large need SRT-XXX+ customers are products the radiation awareness system a focus sold another business oncology an in We're Northeast. important luminary oncologists gaining radiation dermatology among we avenue for

And with to call on bit like a to quarter. more Sardano Michael that for I'd the color overview, turn the over

Michael Sardano

Thanks, Joe. fourth the revenues record well extremely We've both been by year. executing as the for full and high evidenced quarter

will our continue We line expect XXXX beyond therapy devices, and momentum radiation our coming in line growth superficial throughout years. revenue unique the to from continued top lead of which

recently through to expect advance of add devices aesthetic XXXX regulatory the in We part as acquired the process. the revenue we latter materially to our

this a sales experienced have now business. our we dedicated part aesthetic and manage Additionally, of professional to

fourth the Vision. an which Despite of fair higher to value the XX efficient units, to draw shipped as SRT-XXX we lease our rates, During program were quarter, acquire interest interest continues XX our market SRT devices. way

quarter, as Asia. also Our which shipped well most a during units international X to and XXXX doing business fourth went we is during XX of the the record

opening the in new America, on EU. Australia concentrating are and markets We Latin

So enormous we potential the United have States. outside

financial of turn With the a results. Rampolla to Javier that, I'll call our for over discussion

Javier Rampolla

pleasure be afternoon. all Thanks, is with a Michael. speaking to It this of you

was of profit the for Our costs XXXX of yet this XXXX million in with for pressures, $X.X revenues were remains quarter the compares revenues million quarter $XX.X and XXXX. for range the compared $XX fourth of gross our driven primarily all percentage. or of with of revenue of or to higher XXXX, of $X.X in decrease quarter for inflationary XXXX. was our fourth target The of margin the the million mid-Xs XX.X% revenues fourth XX% Gross by the due million manufacturing fourth quarter

the was to higher million expense XXXX. $X.X was increase fourth the quarter The $X.X expense for of advertising Selling attributable and quarter with XXXX higher and General to compared of increased compensation fourth with million along million headcount. marketing higher for fees increase quarter bad quarter expense for expense compensation for was $X.X to fourth and higher XXXX. expense. with and of XXXX of fourth $X.X the million due the debt administrative was compared professional due The primarily

fourth unchanged expense $X.X million, of quarter was XXXX the the Research and for year current from quarter. development

a was XXXX. goods. the diluted extent, fourth $X.X XXXX, decline expense as of for the XXXX attributable diluted in The or fourth provision expect of million and such R&D had income provision quarter or this tax of quarter quarter per net for with per we to no million to tax quarter income and $X.X $X.XX a recorded the largely XXXX. the cost Net of increase in quarter this was general year. to income compares in XXXX $X.XX lesser share for million income level of We remain the $X.X in of fourth each at of We last fourth of share

million year earnings which stock amortization ago. for EBITDA, the as interest, quarter depreciation, with before a million was define Adjusted $X.X taxes, compared fourth and we compensation $X.X expense XXXX

Turning XXXX a XX.X% XXXX increase revenue sold. XX.X% higher on higher service briefly were was compared an revenue higher driven XXXX with The sold in increases installed compared driven units by XXXX, unit to were by in of with $XX.X for $XX.X for units. $XX.X increase million in million for financial a compared reflecting Revenues year were $XX XXXX. $XX.X units million with $XX with due of results. the XX% sales increase revenue The million XXXX to of full and number number million Cost the XXXX of was for sold of or number XXXX. Gross or million for for of demand. profit

and XXXX. million increase $X.X $X was XXXX. $X.X The and for marketing million administrative attributable XXXX expense XXXX million with marketing XXXX. and to development increase compensation for million and expense $X.X $X.X with increase higher higher to for and in The on compared expense. compared Research Selling compared headcount. was expense with debt million for was was $X.X primarily million XXXX due for was spending primarily for activities General bad

As in XXXX with expense be indicated, XXXX. we just I generally expect to consistent R&D

the XXXX with diluted asset, XXXX. million reported XXXX. diluted The of a company for on $X.XX for noncore $X.X to per $XX.X with million The was million diluted sale gain income compared compared compared Net $X.XX million or of per for XXXX increase sale was share. mostly share $X.XX million noncore a $X.X XXXX. for $XX.X a with the $XX.X a $X.XX XXXX related EBITDA or asset. Net was for $XX.X per for was other XXXX, excluding income gain of million or in income million Adjusted on share

ago. of Turning our XX, we to now XX, XXXX, of year December had prepaid $X.X future up receivables equivalents as XXXX. in no with up reflecting its We were or for orders million placed XXXX $X.X from the December from sheet. XX, of million of compared December inventory million in $XX.X XXXX, [indiscernible], $X.X December increase million million balance million as at in as on and million and for outstanding under $XX.X were $XX.X credit sales. inventory in prepaid In December the $XX.X revolving Cash The XX, as in a XXXX, inventories. and $X.X cash company growth million, line of preparation borrowings stood Accounts XXXX. XX,

underscore been I'll for time. have some what we saying

financial front history. to center, continue the and in expense and Our to a management in we is position attention be stronger company's

across. us compelling sheet balance may take positions Our well the growth to opportunity we of come advantage

the a table financial of reconciliation measures. the see a issued release to final in today please GAAP news for comment, we non-GAAP As earlier

With turn the to over Joe. back call that, I'll

Joseph Sardano

Michael. Javier and Thanks,

better position future. challenges has in the As Sensus a said, the Javier Healthcare just never been to of meet

and well are have We momentum. capitalized business

solution portfolio the for SRT we have accurately technology Sentinel for a clinical the ROI new It especially, about data a store attractive for as asset billing This SRT-XXX with products. In to has the and in and Vision Sentinel software. Vision and Sensus addition, our very SRT-XXX and planned allows it HIPAA-compliant management all patient our is physicians software this for changer and customers game and lineup to along the systems. been available demonstrates year, Solutions easily our and enhancements SRT-XXX+ for we're clearly future document purposes. on excited later XXXX, proprietary is and IT

a the have work expanded including to as have Chief at portable tip A include cooling Solutions a artificial embedded and diagnostic laser, capabilities capability already In that doubled to Under smart IT highly them. with aesthetic truly priority we expanding lightweight the I include has is Sentinel ring. laser the capabilities in portfolio silk Technical this will our promoted add engineers we the the and newly new Sentinel. lasers, handpiece, our Officer, and Sentinel months, our focus recent want technology. of lasers, diode to intelligence cold number super repetition X for of indications of Sensus-branded leadership Sensus our to Sensus all X in of

while and distribution. selected efficiency and more penetration area, energy wavelengths by resulting emitting blend better homogeneous maintaining light the in deeper vertically density laser the of to towards ability the skin The the increases in

Importantly, this laser skin making available the laser types, everyone. is sensitive to to all removal

and will this weekend South showcase the Clinical Beach Fall We annual have the also the showcased booth at Silk at Symposium. in our Laser

While the to very we're cleared we once also about excited introduce new next early this excited Silk, and we're later plan about year potential the year FDA. by lasers the of

We patient awareness of increase have digital pleased our We're with up of SRT. marketing as well. our advertising the new early to success initiatives stepped

Our engage Facebook we page remains very active the public. to as work

We patients to activity, visiting continue treatment. resulting to our website which more SEO our many increase will SRT in is about learn

systems not plastic positioned a X,XXX further to consisting more and some in oncologists. X,XXX radiation the offices, are Our Mohs market large of SRT X,XXX well and and a U.S., XX,XXX largely in representing X,XXX surgeons mention dermatologists surgeons untapped than

keloids to compelling of prevent Our solution surgery for surgical systems alternative excision. following patients to provide of only millions arguably, and the recurrence a the

this large In that develop non-melanoma people their with skin condition will X skin contract X skin cancer a This will growing XX lifetime. in country. Americans is during us that nearly estimates in million tells addition, cancer cancer and

need our even So clearly, a SRT future. and in so for both this more is now the systems

strongest support in growth programs, summary, efficiency thoughtful have In to our and team our we with leadership. place ever

and capital technologies to deploying in to deploying new are Sensus, adding force. and We our bringing invest sales in

our evidence of million As repurchased common buyback enthusiasm program. through we future, our stock share our $X for of a

now your ready operator, thank And to take you for we're questions. With those and time attention. comments, I

Operator

Alliance with Partners. [Operator Global will Instructions]. from here question first come Haynor And our Ben

Benjamin Haynor

the offer of submissions going in? that aesthetic laser about are should products, XXX(k) there First on we outside be as color XXX(k)s all going submissions. me, off, that any other might Or And for treat conditions year that those those the lasers? in think this on will are

Joseph Sardano

going going thanks this Good Ben, the variety and that excited going to in submitted be is that offering. we're to nice that have be voice, niche appreciate would for to that I been market being are aesthetic going acquire the that aesthetic going a into are products very, very FDA It's to variety to question. products I a marketplace. tell we've hear your technology, a be to on. unique and of that be of for able products the to But to the you various it's to

Benjamin Haynor

about to do Or approval wait And plan submission? or you Okay. till you let do launch? those investors know upon

Joseph Sardano

the I going be as it's testing result ready with usually bit make of the the But we to a take try either of I we end But equipment think Dermatology regulatory as get with the to the and American as to that the to all through works a And which expecting middle we progress sense and because getting people second around we get approval of by that, to through submit sometime to various we launch XX-day we're say their to it the want as FDA, quarter to announce get of first process process. the period. that until Academy that it to all they data, it's its or quarter, that closer little we would going able since would the could in world meeting. have XXX(k)s, the assembling of time. to go wait this of

Benjamin Haynor

Okay.

So on initial the kind on Got sales [indiscernible] And will apartments it. that -- of on thoughts luminary and Any you of kind cycle there. stay then color oncology require the are interest? Northeast of provide What the oncology. could radiation tuned. radiation level congrats these your the

Joseph Sardano

purchase -- it when the at to very take want to Yes. could The to buy says, months, and they everybody XX as get describe months before difficult hospital when up a XX a we market order. hospital it, it yes, to market, I XX XX is you

in our selling the So cancer. radiation some reduce it's lot This requesting for a to reimbursement we're reasons think centers for hospital seeing cancer. oncology quotes, -- market a there's other to is more of but system one And you to will, market we're are services get if cycle. I that because hard that Medicaid the long and with or skin that that interest involved starting in that Medicare hospitals are see of areas working very in some

the cancer, reductions look to high-volume sources line, are looking breast expense. cancer, other For on at see to if Xx you these lung looking they're And skin the whether one things very they all at your of in cancers hospitals over across not, the instance, skin greater the and when greener is revenue. of all high as they're not reimbursements or , fence, because it's cancer, have types starting cancers We're the or look that to cancer with will, access And of you of those happen, purpose reduction additional cancers if don't starting those at accessed, it's than have market. combined.

yet millions technology other to return areas the So dollars the strong. the is those radiation like oncology of investment compared for and very products them very very, acquisition spend good a of minimal they very on the is in SRT on

that bigger positive in an an I at area not So in cash opportunity the see about look smart I think And they hospitals, hospitals looking that at and addressing. are the additional they're future this SRT. cancer, us asking that are the that think

Benjamin Haynor

is recollection you sense. or more then authorized bit kind the That of activities. me and And aggressive share with there. think the you gotten there Maybe on million I Okay. wrong, lastly the repurchases, X share a to repurchase continue re-up my had little authorization makes for plans but

Joseph Sardano

X we happy the did shares. we the else that million Board as To a think anybody own that. us to as $X in fullest in those the We our provide We we more as extent, very decent were getting million price, good went and and repurchase spent at than is investment investors to think to shares best shares. company. was We the our with Board the

open Board again. that that to And think it across out definitely should is at so the if come like happen, always and look opportunity there opportunity is in the I future? we'll making things the

Operator

next Alex Our with from Nowak question come Craig-Hallum. will

Alexander Nowak

to boost has get out about the physicians, in over them, the When last I'm in The been is with a there reimbursement in this as we and of this the they it, call field out. starting speak all but of we the couple years. physicians. that business what change curious physicians get for the go And all the do minority reimbursement curious that at it, big Just investors, point? a increase physicians still, where it practice? you who would piece get are Or And process do really of figure reimbursement? their

Joseph Sardano

an on. ongoing Appreciate being question. the for thanks process. It's again, Alex,

have with business we very business base has lot them, very, challenges. the to their -- -- You to of to face, a every is. time in a of reminded face very They to are touch every Every these what open. time lot time practices faced we're very, keep be doing it go these busy to individual that we reimbursement with remember owners of they have meetings, things

ongoing. it's so And

push We already increases it the it the that ones ones that the continue reimbursement product. they're to benefits already they have are have because now, recognizing are reaping because the the

year talk move, to busy. we field, impact. go years, now the on the able X continue references think to we're keep good to that's to it meetings doctors was And COVID, these in by have mind That's is we where been gain face. they're in biggest and additional knocking and They're these listening. for face we're additional to year them. As go since that we've where because references or When doors, sales the that I first last

would conversations but But it's to we're additional takes you for comprehend, easy that I getting these to never there, they -- it make sales. them always Sometimes tell and but understand.

the they dollar, everybody you a trying on at we in story have have look to it. percentage get that the technology technology, have competition you we're knocking only the is could is of everybody because no to of would doors dermatologists dollar, in I have well, a who's when tell you say, market, and competition. doing our we the a that good And

I XX% headway. we're last in over year, And that so increase I our making a far, would say that think business

doing think well that we're I there.

looking So and the and the go at. to think I across to that them, to getting that meetings we made, continue achieve as we'll more are we're presentations we are goals

Alexander Nowak

and it building. very -- it's I That's mean sounds helpful. still still like

into So question kind my it here. I of mean second leads

growth You line, also the the on top But and that top bottom committed got year line this think the do side. You've line. to about growth? on on the we dermatology on ramping how

new You've got in through, half. radiation flow to oncology second the this products piece started coming

Just how year? about do growth think we start this to for

Joseph Sardano

of know we you guidance kind Well, expectation guidance, -- we're the piece But us can try hard, for our expectation right I derived, and to and time, future. decisions know provided the and any been that a of very around don't Alex, conservative, ultra be. think I but of that all of time we're and and you've to what there's for levels are. thinking grow we you to long to because get how we if business, always know the I make work assure this, going might very, I should a We're there's think again, they haven't be as company we don't levels but accurate the as sometimes they're kind of I that not

going I this do impact previous to fourth I we'll that it, to and I my better how we FDA at business? that ourselves adding that So to revenue happen the revenue. know are have I have look do to the around think than on year. have of probably whatsoever. We have do think products of of and look And will We to where how the better any going previous we at to quarter challenge year add submissions keep we're based do our team that, year. kind future

portfolio. these business line say top continue grow will grow our our to add to we'll technologies continue that to our organically, well would we our bottom SRT line continue pursue as and that I we'll as as So to

is pain we that we results. has are a think the and that noninvasive again, theme, different, with better add a way a that to better And that else with much of technologies their in are same what anybody no that want provides better what and patient treatment, is provides than experience treatment the and

we're So goal. That's that's what for. our looking

Alexander Nowak

priorities you the M&A here, just then allocation, buyback And the obviously, the thoughts? into helpful. capital did forward, but towards cash go back That's It share business. you the more current for reinvested goes on

Joseph Sardano

The lot is want that companies, we dilute have and we've And to opportunity that's debt. their always what minds, is this of of one a than the go a want probably year. not of our in We committed We've something that things company pay. talked principles of the evaluate still companies lot people willing to had to on M&A is, worth a you to do a to those we're and our lot more do little we're not into shareholders. to believe existing

an that opportunity while at revenue looking for we're portfolio trying time So accomplish with in with that's to what adding same products. to the to add exceptional we're to our going mind,

can we payback than can rapid or that an chew, And so can that portfolio reasonably, we're find a at that technologies we very looking biting to a fairly succession. ROI could add more get rather than we our in off

can trying something look that's that being so months, very, what to for aggressive is X pay to very back And do. XX within what we we're and we for

Alexander Nowak

can sales accounts in on quick, It QX. comment outstanding up maybe you here And did real increase. then did balance? just receivable days spike the The

just So there? that any if items number there's in curious onetime

Joseph Sardano

months, various was, I terms. we customers what -- growth had mean the for revenues had great course we over some some and requested with No. exceptional of some

them we for but good everybody terms, we it. know the So is that with provided

objectives something helping the position, that So cash when time afford you while we it to at encouraging goals and well. look and able as their at were where our customers same our was accomplish

because time, success to more us So as buying our one customers over closely we proven end with the Their work customers. they've system. very than very up important is very,

with instance, has thing we a single done of and have of been him it's customers. with patients, for with sensitivity the doctor, his XX his mean of hasn't our of systems in his helping That business kind with any all I XX our and same offices. that without

so So will when do here helps helps and there business to extending us, continue the that it drive our we term or well. us doesn't as hurt the and customers

Operator

from next question come Chen H.C. our And Wainwright. with will Yi

Unidentified Analyst

on it's that sold related guess, Congratulations all increase Jake Chen. success. fair or of think place the is the primarily marketing This behalf I on have efforts understand in well. the that to Yi I SEO put systems increase digital you in is so SRT guys to exceptionally in

digital So and/or expect be are advertising, very marketing this terms your to expectations guidance, from of you helpful. in relates that any year would related providing for sort you're activity kind the know any expectations that the but of on also the engagement as referring SRT of it and I sales kind what to KOL systems? that, marketing of

And the second the the I visit on systems. that removal Silk on far? so Any feedback, are global is hair as laser removal commercialization especially have hubs where for going? there And I it process quick the markets, on How hair international is people any understand treatment. question update

on helpful. would that be any So color very

Joseph Sardano

for Thanks SEO. regarding that question

Google about day. We approximately per patient X to here in that Page as to within moved on we're SEO, that emphasis, feel pursuing per we've Page continued XX we'll continued up aggressively strategy. X from week Page just inquiries about originally we on where you X we're X. and be with next X. from what accomplished the efforts of X the With We months to XX tell X to months getting at me a went last now Let digital

we as excited in business. progress we're invest and of our part So that

number what Now have done have they inquiry. call as one own also the personnel increase, we and of to expect speaking is, we of involved every inquiries patients those for we patient to the with in our so

that our consults, physical we able with with those And doctors patients with with equipment their have up their doctors, set are in meetings area. to

proximity they've find we choice, more we And and sometimes, or always of out one living. follow them give reached And to their we a that a patients with gaining doctor because up, a of cancer where whole they're are doctors particular it. these out are another but to lot because specifically flow the demanding SRT learn for about those once skin they noninvasive and patients treatment patient approach

with answer we appointments. educate up and So them set their questions the we then we them,

Now that on we're other extremely directing physicians these opportunities the them those to thrilled additional them. are revenue hand, providing patients by

the are many are dermatologists those hand, getting other On those. specific area that getting not patients. not that there to They're in

says not information force, X that of our in course So gets X your you're the directed area we've as don't obviously, sales and months well the that month, how I over seeing. -- know months, many patients last

and as continue to continue as we talk And so this sales to of we becomes tool that to going add program, with marketing and to selling force. a good for lot through working our a our our that's CRM salespeople, and grow

emphasize the existing So person year see going grow to so. the and now to we're is more have into from it advocacy time that more We're going our We several next over patient to group we it. dollars to continue continue going to to it. put into or where

learn about I and And so that, continue than think we're patients more about before. excited will to ever SRT

Regarding a applies very is is a it skin think hair unique because and going product which -- removal, of wavelengths, unique offers because very various this to colors. is we multitude it

so And exciting. is be to this going

it, exposed have we'll more AAD, the is for will Now introduction of period. display be this the to where several of on to units the be at going demonstration people and and real during that

that. So we're for excited

well our expect sell of to that XXXX line. number units the We bottom that will we add course to during our a have as certain top line of as

gain of in we'll lot a that So market area.

take the few keep in announced to that us help also just world did mind a this ago, in market then we level. that we professional aesthetic And weeks hire another a to

so those things revenue to all of the that in the And are more we and add to course, it's heading of feel right company. going direction,

Unidentified Analyst

again. once Congratulations

Operator

with from next question Henry Scott come Our ROTH will Capital.

Scott Henry

Congratulations, Joe. XXXX. tremendous Really a

questions. disconnect. expectations, I recognize the specific growth line And the some there's and growth that XXXX had in been bottom So some I line. on you're I know on seeing top

So I a of from growth wanted base to you're to to pulling specific onetime trying a using XXXX? you get line, -- questions flush When something bottom say out line. the you with for regards are little couple a of events on Just what XXXX sense XXXX. the bottom in

Joseph Sardano

all, okay? there. event, It's one California. on, much Conference So every of Southern -- to bringing great attending to at thanks we're that because The increase always be and line. to we're it's product margins. we ROTH board event, as we our very and March everything well when Capital looking Scott, definitely line, we're a bottom that add those taking Hopefully, is first we're the model out bottom for margin it forward in along in look the to to being adds on excited going in that --

yes, that absolutely our right, of you're and -- still bottom looking we're out So that event taking one at growing line.

Scott Henry

report on I lot start together. for your you mean to on gain Would to And a starting Joe. accounting expect some to to Great. positive thing, as and take have to seeing be and when book a you earnings might I tax assets, fully The -- well, forward. deferred look fully money Javier. have XXXX you a quarters I consistently, going a throw tax to tax you basis at Okay. rules, calculate that another for to forward want And you basis? you're point, stack this you in. tax of make

Javier Rampolla

to. we Yes, have

to. have We

Scott Henry

you rate advise At that Okay. for what time would period?

Javier Rampolla

should we a Yes, least at XX%. maybe that say like forecast a [indiscernible]. at. we're will working bit I

Scott Henry

clarity, over disadvantage. So thinking look started bottom on basis? basis we at be it on growth tax And a the when XXXX should sounds to we then otherwise, for in tax line, a you fully for fully again, XXXX like a

Javier Rampolla

Correct.

Scott Henry

rates Okay. just I'm to come Great. a bolts I to the curious question because the And do higher that with cost the to is lease someone and was you then accommodate customer? the the when has a to little of not to model. does the of just that bit up rates, final of from shrink margins huge but regards get process it's rates. kind kind your the -- program program a Or We lease little nuts revenue amount, with just those increase? that? interest Obviously, higher understand pick of do what you hoping important interest

Joseph Sardano

patients, you to Yes, it's give Vision idea under gone behind that this okay? based rates leases and up SRT-XXX market hikes, that. but patients the the all somewhere those The realization just can't coming before year, fair approximately we've at you beginning, the quarter. always in customer value probably Well, tried to with the these breakup of patient was a it So the it one breakeven around is from into customer, have your directly the quarter some a month. a X tell rate

month. a So just patients X said we

have gone a patients could up, As X it you -- month. the now really rates say it's that

really under over not X it fairly patients So patients a just and X month, it's X month, a it's patients still we're the safe having a month. in

that away doctor's the of whole we're is our other okay? these program in credit you is take they for sheet worth But doctors money customer lot or any that physicians credit line, So what have put to way. the nonrecourse real is mind a off-balance where that offering a keep the to from itself don't that their doesn't opportunity in regular to have in

gives need this the because and is tools all to that to which program a they great what has all things Vision afford able be benefits. for So is the it they and want product, of them, it them the

to you pose also Let that me go question to previous the Javier.

the we for -- to paid alone fourth quarter, IRS. quarter This million the in $X.X

to want going than IRS, to it's $X million to going be million, $X.X of to Our money, probably a $X.X million the be lot closer and goal is right? pay to probably the more and it's but And to to to all pay we to IRS. continue to continue

So paying that but more earnings that's an for money, making even forward XXXX. whoever but accounted have share that think happy were, we're because to it and derived whatever that, per for wasn't pay by we we're to objective our look we I

Scott Henry

a Well, tax least at date. based you're in down low

Operator

Instructions]. [Operator

next Maxim will Our from Vendetti question of come Group. Anthony

Anthony Vendetti

have market. may rates fair Joe, impact, the you the only about they on some XXXX sales. talked the but Interest patients. market but lease lease, that's about being talked it's program about maybe went helped you fair fair program said, had up, X.X to a So value market X, obviously, with you as another see value

-- able then profitable. be profitable. numbers The not think after to it still a it's month, month it's X.X getting I exactly like to now itself that. just make those think still one -- and comes words, might be see a In I a I program Could other X.X, right. it was if they you still month,

just you me. go that through with if So

can And lease -- much on impact think value And what's of What an or you interest your And the to program? how fair you approximately as the rates for think that this then outlook the sales be has XX% say, market best just sales in your same was had rising quarter. was that do trend last on you expect quarter? program? of it it 'XX? I

Joseph Sardano

that The told they was patient but breakup again, a patients, patients when breakeven. patient was can't either that fair market quarter It's back you required X still introduced go It to X.XX, we full times analogy in we to the customer into X.X but the Anthony. half. interest or -- Okay. the about Thanks, the not. or low, lease, actually month rate a a I'll early a value

the as So were requires month. conservative X a customer we told consistently patients we being as

over is slightly still pro increased but we It's Now but a month. patients under, patient, of the still with a we really a the it, X still X increase show the X/X patients month. based it year in last on maybe claim formas X Fed about as

conversation but the of physicians does it are with increase. additional require the that, because an okay And

it's like is interest we your So oh, not say, rate X%. okay,

okay, and now is have We go your X%. say, interest rate to to

requires the a So breakeven two additional and go conversation to difference, through there but month. or that, X is it a patients an still is

good, still less any the month. saying. Now still a the XX provides than our doing we and to very, customers It patients get technology, ROI them into as were see don't of still we opportunity is that very

they So don't have a shortage of patients.

of And personal don't X that doctor, X with is is bring in tremendously up sheet to years, for personal is Not a fair the -- they means important, this. them when market signing guarantees are into you have he's and this a deal we in it's to come especially off-balance then nonrecourse no-brainer, its years, telling they financing need go than sheet the is are business having that their CPAs any off-balance for it's doctors and guarantees. the CPAs. Their the with lease, more in business value lease if characteristics big which fact all point that

have Now with the with still in being seeing of buying they to because cash the the products. cash said, the all have that we're volume, they cash, majority buy and the physicians confidence the the They okay? have

-- the cash it. push of market majority these do to it the great when a their lease conversation, outright? You to to it saying, our the and cash to purchases. sales And their is starting end got So CPAs shove value get comes comes adjunct with fair but still they're talk buy and are to the are into CPAs, the

Section it has a lot IRS to of code. do with of XXX -- think I the

and and was talking time talking called of the at sitting the just and first Sensus machine. we we the buying says, at of a with now month physician remember, the our say dinner dinner December I'm that his financial hear And X. we is often, took telling a him say, about And in with about a his were I And about having I CPA something buy at you could he him system. before round could the there that well, a he sitting the situation were bite, end buying buy. And CPA guys story

guy sold being needed was CPA money deduction. a made tax but because buy one, said, So so we X, much the that's only and there that the

it tool when It's a that's to tremendous So a for in topic been the tremendous cash. shove, value fair It's doctors push buying conversation. with of lease. But majority comes us. these market the of is again, where are

Anthony Vendetti

yes, And I helps quarter sales. always with fourth Okay. no, XXX know out Section

that, In to because of any no? there basis. sort sales at terms Were China or volatile know I China of that's quarter all on a this quarterly been

Joseph Sardano

of to best announced overall that we -- year sending had We X to units China. had shipped our altogether. for Yes. selling systems we year, all the XX And Asia

and in sold another we Korea there where Now Taiwan was unit. was one place the

China, So units had you to XX overall Asia. to units XX

in that to a locked that's year, keep year. That's for good everything mind you especially the in really We problem China, and that have So up. the up entire very -- COVID there. starting open

States. prior year, just their allowed new traveling to COVID overseas, from be their the came lot up citizens opened many which to China understand, a United which of of to we As

business hoping think in to if better that's Asia are which So do it we open, good but even China for we will, XXXX, a remains us. for

Anthony Vendetti

have then last little talk And feedback you've of in you know the terms Do laser a question just hair Silk Great. system. introduced Okay. I on about bit? removal orders? that you that. any Can

Joseph Sardano

mean I very, October. positive Las in Fall Clinical in Yes. introduction the Vegas very the the feedback at been has initial from

the a we're being And we to that be the drive what successful that's real hired we've going some that does as multiple with exactly volume is unique. with our what be business, is consumables, range aesthetics So prospect far our It It going low used think portable. good I consider generated effective without seeing base. have cost, specialty to now guy we're is product at can are is who's energies very physicians which because a cost that It requesting. it the as simultaneously. and

it more going So I as going think show more we we're think be we I start as selling become to to that that be more known to more, systems.

Winter be X later at at also weekend. to clinical, Dermatology, it several of American will have going It's will units displayed or following meeting be this weeks Fall We available displayed. upcoming the Academy the the the

exposure, gain think some sales And so coming going to as about. see we that I we're

about excited we're it. So

Operator

Sardano I'd the conference That's all turn have today. remarks. to closing time Joe over question-and-answer for like session. our the we for this concludes to questions And back

Joseph Sardano

Healthcare. skin the thank to also listen, to there cancer thank forward again, the being forward for In our XXth their on We in you our held presenting meantime, very wish and the at want we'll next interest time we another noninvasive you and solution Sensus And I ever-demanding our for be seeking on. Annual thank for needs. Conference. a this repeat that want Laguna, in best hope through to I Thank at May. your talking results you, of Well, ever as to Okay. once conference see that to being as in patient the early everybody, again to Again, you you we've It's is to for technology, looking California, your mention position We're much. XXth XX look questions. Sensus ROTH afternoon the many our you population March you. and been great year. Healthcare possible. to in people, Thank based that

Operator

now Thank very attending has you The for today's presentation. conference much concluded.

lines. may disconnect your now You

Sensus Healthcare (SRTS) 9 Feb 232022 Q4 Earnings call transcript